Decline in revenue or profit

Hong Kong IPO disclosure precedents · 189 companies, 196 items

a fall in revenue, gross margin or profit in the track record or after it (recent developments), and its causes

2026-05-08Application Proof
GUANGDONG TINOOS GROUP CO., LIMITED广东天农集团股份有限公司

In 2025, our gross profit declined, mainly due to a decrease in the average selling price of pigs, from RMB2,281.6 per head in 2024 to RMB1,897.8 per head in 2025, whereas Qingyuan Chicken and other native chickens remained a positive contributor to our gross profit.

Summary · p. 9

The decrease was mainly due to downward market conditions in both chicken and pig prices.

Financial Information · p. 230

As a result of the foregoing, our profit before taxation of RMB890.1 million for 2024 changed to a loss before taxation of RMB101.3 million for 2025.

Financial Information · p. 231
The company's explanation, the adviser's view and the page in the filing: see Matters
2026-05-08Application Proof
GoNature Outdoor Sports Group Co., Ltd.奔赴自然户外运动集团股份有限公司

Our adjusted net profit margin (non-HKFRS measure) decreased from 17.2% in 2024 to 14.6% in 2025, mainly because we opened more offline retail stores which typically have higher store operation expenses.

Summary · p. 12

In 2023, 2024 and 2025, our selling and distribution expenses amounted to RMB277.2 million, RMB586.5 million and RMB1,058.7 million, respectively, representing 30.5%, 33.2% and 37.9% in terms of our total revenue, respectively.

Business · p. 139
The company's explanation, the adviser's view and the page in the filing: see Matters
2026-05-06Application Proof
Kexing Biopharm Co., Ltd.科兴生物制药股份有限公司

During the Track Record Period, the gross profit margin of our direct sales was lower than that of sales through distributors primarily due to (i) the relatively low gross profit margin of the promotion services for Reminton (类停^®^); and (ii) the relatively low gross profit margin of drug substances of EPOSINO (依普定^®^) and WHITE-C (白特喜^®^) sold to overseas markets.

Business · p. 163

Although the VBP schemes have resulted in lower average selling prices and narrower gross profit margins for the relevant products, our revenue relating to pharmaceutical products generated from domestic sales remained stable and our overall gross profit margin declined insignificantly, as we were able to increase sales volumes, enhance utilization of our manufacturing capacity and realize economies of scale, which helped offset the impact on our financial performance.

Business · p. 170
The company's explanation, the adviser's view and the page in the filing: see Matters
2026-04-29Application Proof
Eccogene Inc.诚益生物开曼有限公司

For the year ended December 31, 2024 and 2025, the revenue generated from the customer amounted to US$221.3 million and US$0.6 million, respectively.

Summary · p. 8

Our income tax expenses decreased from US$47.4 million in 2024 to US$0.1 million in 2025, primarily due to the lower revenue and profit during 2025.

Financial Information · p. 235
The company's explanation, the adviser's view and the page in the filing: see Matters
2026-04-29Application Proof
Shanghai Fullhan Microelectronics Co., Ltd.上海富瀚微电子股份有限公司

Revenue from direct sales decreased consecutively from RMB1,475.5 million in 2023 to RMB1,233.8 million in 2025.

Business · p. 137

Gross profit from direct sales decreased consecutively from RMB554.5 million in 2023 to RMB434.8 million in 2025.

Business · p. 137

In 2023, 2024 and 2025, our gross profit margins were 37.6%, 37.2% and 36.6%, respectively.

Financial Information · p. 177
The company's explanation, the adviser's view and the page in the filing: see Matters
2026-04-28Application Proof
COLIPU TECHNOLOGIES GROUP CO., LTD.科力普科技集团股份有限公司

Our overall gross profit margin was 8.1%, 7.7% and 7.4% in 2023, 2024 and 2025, respectively.

Financial Information · p. 163

As these categories differ in pricing dynamics and procurement costs, changes in product mix affected both gross profit and gross profit margin.

Financial Information · p. 163

Leveraging our centralized product governance and supply chain management framework, we seek to optimize procurement costs, improve pricing and sourcing efficiency and support margin improvement over time.

Financial Information · p. 163
The company's explanation, the adviser's view and the page in the filing: see Matters
2026-04-24Application Proof
Makesense Energy Technology Co., Limited美克生能源科技股份有限公司

Our revenue was RMB174.2 million, RMB124.6 million, and RMB520.0 million in 2023, 2024, and 2025, respectively.

Summary · p. 5

Our relatively low revenue in 2023 and 2024 was primarily due to our strategic focus on the modern electricity service market, which is still at an early stage to date.

Financial Information · p. 164

The gross profit margin of electricity services was 48.9%, 38.0%, and 22.0% in 2023, 2024, and 2025, respectively.

Financial Information · p. 164
The company's explanation, the adviser's view and the page in the filing: see Matters
2026-04-17Application Proof
Capital Securities Corporation Limited首创证券股份有限公司

For the years ended December 31, 2023, 2024 and 2025, the comprehensive rate of return of our equity securities investment business was 0.50%, negative 0.27% and 6.19%, respectively.

Business · p. 126

The comprehensive rate of return of negative 0.27% in 2024 was mainly attributable to an intense A-share market volatility throughout the year which impacted certain equity investment strategies, such as quant market-neutral strategies, leading to a modest drawdown in our equity securities investment portfolios.

Business · p. 126
The company's explanation, the adviser's view and the page in the filing: see Matters
2026-04-13Application Proof
Nova Insight Technology Limited暖哇洞察科技有限公司

In several months of 2025, an industry-wide control on telecom service capacity temporarily reduced the efficiency of Jiangsu Daotai’s AI-driven outbound calls, which constrained our service capacity.

Summary · p. 13

Revenue generated from Customer A subsequently decreased from RMB189.8 million in 2024 to RMB62.8 million in 2025, primarily we mainly provided customer engagement to Customer A, and an industry-wide control on telecom service capacity in several months in 2025, which temporarily reduced the efficiency of Daotai’s AI-driven outbound calls and constrained our service capacity for Customer A.

Business · p. 154

Notably, we entered into 17 new agreements to provide our solutions to insurance companies, among which 3 are agreements with life insurance companies subsequent to December 31, 2025 and as of the Latest Practicable Date.

Summary · p. 14
The company's explanation, the adviser's view and the page in the filing: see Matters
2026-04-02Application Proof
Shanghai Huilun Pharmaceutical Co., Ltd.上海汇伦医药股份有限公司

The higher number of terminations in 2024 resulted from our strategic decision to optimize our distribution network, coupled with the normalization of demand for Xiwena.

Business · p. 162

By comparison, sales of Xiweina in 2023 were mainly concentrated in the first half of the year due to strong COVID-related demand, and the associated trade receivables had been substantially collected by year-end.

Financial Information · p. 229

Despite fluctuations in demand during the outbreak and the subsequent ease of COVID-19, Xiweina is well-positioned to capture long-term growth given its exclusive market position, which provides pricing flexibility and creates competitive barriers.

Financial Information · p. 217
The company's explanation, the adviser's view and the page in the filing: see Matters
2026-04-02Application Proof
Guangdong CHJ Industry Co., Ltd.广东潮宏基实业股份有限公司

Our net profit decreased from RMB330.0 million for FY2023 to RMB169.2 million for FY2024, which was primarily due to increase in impairment of goodwill by RMB137.4 million, as business development of FION fell short of expectation.

Summary · p. 6

The decrease in adjusted net profit in FY2024 was primarily attributable to impairment of goodwill of RMB176.8 million.

Summary · p. 6
The company's explanation, the adviser's view and the page in the filing: see Matters
2026-04-02Application Proof
Zhejiang Maoyuanchang Eyewear Co., Ltd.浙江毛源昌眼镜股份有限公司

Our revenue decreased from RMB272.1 million in 2023 to RMB250.4 million in 2024, representing a year-on-year decline of 8.0%.

Summary · p. 11

Our profit for the year decreased from RMB37.1 million in 2023 to RMB18.1 million in 2024. Such decrease was primarily due to the decrease in revenue as mentioned above and increase in selling expenses mainly driven by increased staff costs resulting from higher average salaries; (ii) an increase in marketing and sales expenses mainly attributable to a brand upgrade launch campaign.

Summary · p. 11

Our profit for the year increased to RMB41.2 million in 2025, primarily due to increase in gross profit margin and decrease in selling expenses due to the absence of the brand upgrade launch campaign.

Summary · p. 11
The company's explanation, the adviser's view and the page in the filing: see Matters
2026-04-02Application Proof
Shanghai Innovatech Information Technology Co., Ltd.上海易景信息科技股份有限公司

Within such market trend, the selling volume of our smart terminal products, for example, increased from 8.1 million units in 2023 to 13.0 million units in 2024, and slightly decreased to 12.0 million units in 2025.

Financial Information · p. 186

The decrease in transaction amount in 2025 was mainly because of shortage of memory supply in the industry, resulting in a decrease in shipping volume.

Business · p. 144

Our Directors have confirmed that up to the date of this document there has been no material adverse change in our financial or trading position or prospects since December 31, 2025, being the end date of the years reported in the Accountants’ Report in Appendix I to this document

Summary · p. 13
The company's explanation, the adviser's view and the page in the filing: see Matters
2026-04-02Application Proof
Suzhou Canmax Technologies Limited苏州天华新能源科技股份有限公司

Our trade and bills receivables decreased from RMB609.4 million as of December 31, 2023 to RMB374.3 million as of December 31, 2024, primarily attributable to (i) a decrease in trade receivables due to reduced sales value in line with market price trend, and (ii) a decrease in the bills receivable, reflecting a reduction in transactions settled using bills with higher credit risk ratings during the period.

Financial Information · p. 187

Our inventory turnover days increased from 84 days in 2023 to 129 days in 2024, primarily due to higher finished goods balances for new energy lithium-ion battery materials at the end of 2024, as well as lower revenue in 2024 resulting from the decline in market prices for lithium compound products.

Financial Information · p. 187

During the Track Record Period, we achieved consistent growth in total sales volume for our new energy lithium-ion battery materials, from 65,286 tons in 2023 to 96,506 tons in 2024 and further to 114,434 tons in 2025.

Financial Information · p. 167
The company's explanation, the adviser's view and the page in the filing: see Matters
2026-04-01Application Proof
Milian Technology Inc.米连科技有限公司

Yidui’s average DAUs decreased from 1.8 million in 2023 to 1.5 million in 2025, and its average MAUs declined from 5.5 million in 2023 to 4.8 million in 2025.

Business · p. 156

The decreases primarily reflected our strategic shift in 2023 from user base expansion to balanced focus on user growth, quality and value.

Business · p. 156

Yidui’s seven-day retention rate remained relatively stable at 68.6%, 72.4%, and 71.9% during the Track Record Period despite the fluctuations in its DAU and MAU, which demonstrates the stability of our core user base and stickiness.

Business · p. 156
The company's explanation, the adviser's view and the page in the filing: see Matters
2026-03-31Application Proof
Alkaidsemi (Shanghai) Technologies Corporation瑶芯微(上海)电子科技股份有限公司

Our revenue decreased from RMB432.7 million in 2023 to RMB383.2 million in 2024, primary due to a decline in revenue from Si power devices, as a result of overall decline in Si power device ASP as well as lower sales of our FRD products, which has higher ASP among our Si power devices.

Summary · p. 11

Our revenue increased to RMB541.5 million in 2025 from RMB383.2 million in 2024, driven by strong growth in SiC power devices following commercialization of products that have completed customer validation, and expanding sales volume as well as ASP in Si power devices amid a broader market recovery.

Summary · p. 11
The company's explanation, the adviser's view and the page in the filing: see Matters
2026-03-30Application Proof
Kunshan Wanyuantong Electronics Technology Co., Ltd.昆山万源通电子科技股份有限公司

While revenue increased, gross margin declined due to higher cost structures and pricing dynamics.

Financial Information · p. 198

As a result of the foregoing, profit for the year increased from RMB123.3 million in 2024 to RMB124.7 million in 2025, representing a 1.1% increase.

Financial Information · p. 198

Revenue growth was driven primarily by increased sales volume of multilayer PCBs, while gross profit and margin were affected by changes in pricing, raw material costs and product mix.

Financial Information · p. 200
The company's explanation, the adviser's view and the page in the filing: see Matters
2026-03-29Application Proof
Joinsilicon Microelectronics (Beijing) Co., Ltd.中茵微电子(北京)股份有限公司

Although our gross profit decreased from RMB160.3 million in 2024 to RMB134.3 million in 2025 despite revenue growth from RMB347.6 million in 2024 to RMB484.2 million in 2025, this mismatch between revenue growth and gross profit growth was primarily due to (i) a decrease in gross profit of chip design from RMB94.4 million in 2024 to RMB32.5 million in 2025 and an increase in gross profit of chip delivery from RMB4.4 million in 2024 to RMB65.7 million in 2025, resulting in stable gross profit of chip design and chip delivery combined in 2024 and 2025, and (ii) a decrease in gross profit of IP license from RMB61.5 million in 2024 to RMB36.2 million in 2025.

Financial Information · p. 164

Our overall gross profit margin normalized from 46.1% in 2024 to 27.7% in 2025, primarily due to a decrease in gross profit margin of chip design from 40.8% in 2024 to 16.0% in 2025, partially offset by an increase in gross profit margin of chip delivery from 18.8% in 2024 to 27.6% in 2025.

Financial Information · p. 163
The company's explanation, the adviser's view and the page in the filing: see Matters

Tell us